Thierry Canton

1.3k total citations
17 papers, 1.0k citations indexed

About

Thierry Canton is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Thierry Canton has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 10 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in Thierry Canton's work include Neuroscience and Neuropharmacology Research (10 papers), Ion channel regulation and function (3 papers) and Alzheimer's disease research and treatments (3 papers). Thierry Canton is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Ion channel regulation and function (3 papers) and Alzheimer's disease research and treatments (3 papers). Thierry Canton collaborates with scholars based in France, Germany and Netherlands. Thierry Canton's co-authors include Laurent Pradier, Adam Doble, Véronique Blanchard, Günter Tremp, Oliver Wirths, Bruno Bonici, Thomas A. Bayer, Jesús Bénavidès, Patrick Benoit and Jean‐Michel Itier and has published in prestigious journals such as American Journal Of Pathology, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

Thierry Canton

16 papers receiving 990 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thierry Canton France 11 568 434 390 201 193 17 1.0k
Patrick N. Pompl United States 7 644 1.1× 213 0.5× 335 0.9× 124 0.6× 213 1.1× 8 1.1k
E. J. Mufson United States 9 517 0.9× 438 1.0× 500 1.3× 196 1.0× 195 1.0× 11 1.6k
Jane M. Johnston United States 17 726 1.3× 301 0.7× 375 1.0× 127 0.6× 140 0.7× 24 1.5k
John M. Candy United Kingdom 18 217 0.4× 370 0.9× 374 1.0× 137 0.7× 233 1.2× 29 890
Marianne Hallupp Australia 17 727 1.3× 303 0.7× 675 1.7× 460 2.3× 165 0.9× 25 1.3k
Sophie Sokolow United States 18 598 1.1× 492 1.1× 541 1.4× 74 0.4× 169 0.9× 25 1.2k
Olivia Gorostiza United States 18 1.1k 2.0× 553 1.3× 922 2.4× 172 0.9× 357 1.8× 25 2.2k
Brian Anderton United Kingdom 18 778 1.4× 603 1.4× 815 2.1× 174 0.9× 173 0.9× 40 1.6k
Hiroki Sasaguri Japan 14 737 1.3× 267 0.6× 547 1.4× 232 1.2× 147 0.8× 32 1.3k
Smita Majumder United States 7 924 1.6× 311 0.7× 650 1.7× 336 1.7× 310 1.6× 7 1.7k

Countries citing papers authored by Thierry Canton

Since Specialization
Citations

This map shows the geographic impact of Thierry Canton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Canton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Canton more than expected).

Fields of papers citing papers by Thierry Canton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Canton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Canton. The network helps show where Thierry Canton may publish in the future.

Co-authorship network of co-authors of Thierry Canton

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Canton. A scholar is included among the top collaborators of Thierry Canton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Canton. Thierry Canton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Pradier, Laurent, Caroline Cohen, Véronique Blanchard, et al.. (2013). P4–285: SAR228810: An antiprotofibrillar beta‐amyloid antibody designed to reduce risk of amyloid‐related imaging abnormalities (ARIA). Alzheimer s & Dementia. 9(4S_Part_20). 15 indexed citations
2.
Casas, Caty, Nicolas Sergeant, Jean‐Michel Itier, et al.. (2004). Massive CA1/2 Neuronal Loss with Intraneuronal and N-Terminal Truncated Aβ42 Accumulation in a Novel Alzheimer Transgenic Model. American Journal Of Pathology. 165(4). 1289–1300. 331 indexed citations
3.
Pradier, Laurent, et al.. (2004). P4-328 The squalene synthase inhibitor RPR 107393A reduces Aβ peptide level in an APP transgenic mouse model. Neurobiology of Aging. 25. S568–S568.
4.
Blanchard, Véronique, Saliha Moussaoui, Christian Czech, et al.. (2003). Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice. Experimental Neurology. 184(1). 247–263. 241 indexed citations
5.
Canton, Thierry, Georg Andrees Böhme, Alain Boireau, et al.. (2001). RPR 119990, a Novel α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Antagonist: Synthesis, Pharmacological Properties, and Activity in an Animal Model of Amyotrophic Lateral Sclerosis. Journal of Pharmacology and Experimental Therapeutics. 299(1). 314–322. 33 indexed citations
6.
Canton, Thierry, Alain Boireau, Serge Mignani, et al.. (2001). RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis.. PubMed. 299(1). 314–22. 57 indexed citations
7.
Canton, Thierry, Jeremy Pratt, Jean‐Marie Stutzmann, Assunta Impérato, & Alain Boireau. (1998). Glutamate uptake is decreased tardively in the spinal cord of FALS mice. Neuroreport. 9(5). 775–778. 58 indexed citations
8.
Doble, Adam, et al.. (1995). The mechanism of action of zopiclone. European Psychiatry. 10(S3). 117s–128s. 28 indexed citations
9.
Canton, Thierry, et al.. (1993). Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes. European Journal of Pharmacology. 235(2-3). 283–289. 180 indexed citations
10.
Doble, Adam, Thierry Canton, O. Piot, et al.. (1993). RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.. Journal of Pharmacology and Experimental Therapeutics. 266(3). 1213–1226. 7 indexed citations
11.
Canton, Thierry & Adam Doble. (1992). EVIDENCE FOR DIFFERENT BINDING DOMAINES ON THE GABAA/BENZODIAZEPINE RECEPTOR FOR BENZODIAZEPINES AND CYCLOPYRROLONES.. Clinical Neuropharmacology. 15. 620B–620B. 2 indexed citations
12.
Doble, Adam, et al.. (1992). The pharmacology of cyclopyrrolone derivatives acting at the GABAA/benzodiazepine receptor.. PubMed. 47. 407–18. 15 indexed citations
13.
Canton, Thierry, et al.. (1992). A Rapid Filtration Assay for the Glycine Binding Site on the NMDA Receptor in Rat Cortical Membranes using [3H]Dichlorokynurenic Acid. Journal of Pharmacy and Pharmacology. 44(10). 812–816. 26 indexed citations
14.
15.
Lévi, Françis, Jesús Bénavidès, Yvan Touitou, et al.. (1986). Circadian rhythm in peripheral type benzodiazepine binding sites in human platelets. Biochemical Pharmacology. 35(15). 2623–2625. 7 indexed citations
16.
Fur, G. Le, et al.. (1981). Evidence for a coupling between dopaminergic receptors and phospholipid methylation in mouse B lymphocytes. Life Sciences. 29(26). 2737–2749. 29 indexed citations
17.
Fur, G. Le, et al.. (1981). Stereospecificity of the in vitro and in vivo blockade of β-receptors by FM 24, a slowly reversible ligand. Life Sciences. 29(24). 2481–2489. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026